增强型体外反搏联合中药治疗慢性心衰患者疗效影响的网状Meta分析

摘要/Abstract

摘要： 目的运用网状Meta分析方法,对增强型体外反搏技术联合中药治疗慢性心衰的临床疗效进行系统评价。方法在Pubmed、Cochrane Library、Web of Science、万方数据库、中国知网以及维普库中,筛选研究了2023年3月31日之前所发表的所有有关增强型体外反搏技术联合中药治疗慢性心衰的随机对照试验,所有数据处理均采用RevMan 5.3软件。结果最终纳入15项研究成果,共计1280例患者。数据结果显示：①在试验组中,左室射血分数（LVEF）表现更优（95%CI：3.72~9.47,P<0.001）;②6 min步行试验（6MWT）结果也优于对照组（95%CI：27.62~65.99,P<0.001）;③N端脑利钠肽前体（NT-proBNP）较对照组降低（95%CI：-353.25~-18.61,P=0.03）;④心功能疗效优于对照组（95%CI：1.01~1.50,P=0.04）;⑤中医证候疗效优于对照组（95%CI：1.05~1.38,P=0.009）;⑥一氧化氮（NO）较对照组增高（95%CI：1.34~23.04,P=0.03）;⑦临床疗效也优于对照组（95%CI：1.11~1.30,P<0.001）。结论在维持西医治疗的基础上,利用增强型体外反搏技术辅以中药治疗,能有助于改善慢性心力衰竭患者的LVEF、6MWT、心功能、中医证候、NO以及整体临床效果,同时能降低NT-proBNP的水平。

关键词: 体外反搏, 中药, 慢性心力衰竭, 网状Meta分析

Abstract: Objective A systematic evaluation of the clinical efficacy of enhanced extracorporeal counterpulsation technique combined with traditional Chinese medicine in the treatment of chronic heart failure using reticulation meta-analysis. Methods A thorough search was conducted across PubMed, the Cochrane Library, Web of Science, Wanfang database, China Knowledge Network, and Wikipedia library. All Randomized Controlled Trials (RCTs) up to March 31, 2023, examining the combined use of EECP technique and TCM in the treatment of chronic heart failure were scrutinized and studied. All data was processed using RevMan 5.3 software. Results Fifteen studies were ultimately included, encompassing a total of 1,265 patients. The outcomes showed that: ① In the experimental group, Left Ventricular Ejection Fraction (LVEF) performed better (95%CI: 3.72~9.47, P<0.001);② The results of the 6-minute walk test (6MWT) were also superior to the control group (95%CI: 27.62~65.99, P<0.001);③ N-terminal pro-Brain Natriuretic Peptide (NT-proBNP) was lower in the experimental group compared to the control group (95%CI: -353.25~-18.61, P=0.03);④ Cardiac function was more efficacious than that of the control group (95%CI: 1.01~1.50, P=0.04);⑤ The efficacy of Traditional Chinese Medicine was superior to the control group (95%CI: 1.05~1.38, P=0.009);⑥ Nitric Oxide (NO) levels increased compared to the control group (95%CI: 1.34~23.04, P=0.03);⑦ Overall clinical efficacy was also superior to the control group (95%CI: 1.11~1.30, P<0.001). Conclusion Adding EECP and TCM to a solely Western medical treatment regimen has shown improvements in LVEF, 6MWT, cardiac function, the efficacy of TCM, NO levels, and overall clinical efficacy. It also effectively reduced the levels of NT-proBNP in patients with chronic heart failure.

Key words: enhanced external counterpulsation, traditional chinese medicine, chronic heart failure, network Meta-analysis

中图分类号:

R256.2

傅婷婷, 温志浩. 增强型体外反搏联合中药治疗慢性心衰患者疗效影响的网状Meta分析[J]. 中华养生保健, 2024, 42(24): 9-14.

FU Ting-ting, WEN Zhi-hao. Net Meta-analysis of Enhanced External Counterpulsation Combined with Traditional Chinese Medicine in the Treatment of Chronic Heart Failure[J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(24): 9-14.

参考文献

[1] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.慢性心力衰竭基层诊疗指南(2019年)[J].中华全科医师杂志,2019,18(10):936-947.
[2] 《中国心血管健康与疾病报告》编写组.《中国心血管健康与疾病报告2020》概述[J].中国心血管病研究,2021,19(7):582-590.
[3] 庄利斯,熊志华.中药联合体外反搏治疗冠心病慢性心力衰竭的临床观察[J].中国民间疗法,2020,28(18):79-81.
[4] AHLBOM M, HAGERMAN I, STAHLBERG M, et al.Increases in Cardiac Output and Oxygen Consumption During Enhanced External Counterpulsation[J]. Heart, lung & circulation,2016,25(11):1133-1136.
[5] 曾宪涛,包翠萍,曹世义,等.Meta分析系列之三:随机对照试验的质量评价工具[J].中国循证心血管医学杂志,2012,4(3):183-185.
[6] 陈晖. 益气活血方联合增强型体外反搏治疗慢性心力衰竭的临床观察[J].心血管病防治知识,2022,12(29):7-11.
[7] 陈用贵,宫丽鸿,杨柏松,等.稳斑汤联合增强型体外反搏治疗冠心病不稳定型心绞痛临床研究[J].临床军医杂志,2018,46(10):1169-1171.
[8] 段爱晶. 芪苈强心胶囊联合体外反搏治疗阳虚水停型慢性心力衰竭的临床研究[D]滨州:滨州医学院,2019.
[9] 计惠红,赵璨,刘嘉莉,等.芪苈强心胶囊联合增强型体外反搏治疗对射血分数降低的老年慢性缺血性心力衰竭病人心功能的影响[J].实用老年医学,2022,36(4):397-399.
[10] 姜丹,宫丽鸿.强心汤联合增强型体外反搏治疗慢性心力衰竭的临床研究[J].中国中医急症,2018,27(3):456-458.
[11] 孔繁宇,魏峥,富蓉,等.增强型体外反搏联合麝香保心丸治疗急性心肌梗死伴左心衰的疗效观察[J].中医临床研究,2015,7(13):15-17,20.
[12] 李观平,廖远雄.增强型体外反搏治疗仪联合麝香保心丸治疗急性心肌梗死合并急性左心衰竭的效果[J].当代医药论丛,2020,18(12):28-30.
[13] 李明臣. 增强型体外反搏联合麝香保心丸治疗急性心肌梗死伴左心衰疗效观察[J].现代中西医结合杂志,2017,26(16):1807-1809.
[14] 牛艳飞,李晓红,王丽.体外反搏联合芪蛭三七汤对气虚血瘀证稳定型心绞痛患者心功能及血清SOD的影响[J].现代中西医结合杂志,2021,30(28):3166-3169.
[15] 任龙,宫丽鸿.复方强心汤联合体外反搏治疗慢性心力衰竭(气虚血瘀水停证)的临床研究[J].中国中医急症,2017,26(8):1320-1322,1339.
[16] 苏学旭,李惠平,刘静.体外反搏联合芪蛭三七汤对稳定型心绞痛患者心功能影响的临床观察[J].贵州医药,2013,37(11):985-987.
[17] 孙彦琴. 中医药联合体外反搏治疗难治性心绞痛临床研究[J].中医学报,2017,32(8):1495-1498.
[18] 王龙,胡学敬,刘翠.麝香保心丸联合体外反搏治疗气虚血瘀型稳定型心绞痛的疗效观察[J].现代药物与临床,2023,38(2):335-339.
[19] 张宝霞,李建玲,褚亚红.通心络联合增强型体外反搏对冠心病心绞痛患者血管内皮功能、心肌灌注水平和心功能的影响[J].临床医学研究与实践,2022,7(30):44-47.
[20] 黄燕妮. 曲美他嗪联合辅酶Q10治疗高龄慢性心力衰竭的效果[J].中国当代医药,2019,26(7):61-64.
[21] 韩杨杨,王海娟,韩玉洁,等.基于网络药理学及实验验证探讨益气温阳活血利水中药组分配伍防治慢性心力衰竭作用机制[J].天然产物研究与开发,2023,35(4):677-692.
[22] 王晶,高海旺,李月萍.中药黄芪水煎剂对慢性心衰患者内分泌激素及心功能影响研究[J].中国生化药物杂志,2015,35(5):101-104.
[23] 李雨晴,张孟材,叶张章,等.人参强心汤联合美托洛尔治疗慢性心力衰竭的效果分析及对血清指标和心功能的影响[J].湖南师范大学学报(医学版),2021,18(3):226-229.
[24] 郭娇,侯明杰,吴艳婷.增强型体外反搏术治疗不稳定型心绞痛的临床疗效系统评价[J].中国循证心血管医学杂志,2018,10(6):657-660.
[25] 梁塑臻,钱孝贤.增强型体外反搏在心血管疾病康复中的应用与研究进展[J].新医学,2022,53(4):229-233.
[26] 郭飞杰. 不同左室射血分数慢性心力衰竭患者的临床特征及预后相关指标分析[J].大医生,2022,7(11):124-127.
[27] 《基层医院心力衰竭临床诊疗中B型利钠肽和N末端B型利钠肽原的应用中国专家建议》专家组.基层医院心力衰竭临床诊疗中B型利钠肽和N末端B型利钠肽原的应用中国专家建议[J].中华全科医师杂志,2017,16(3):169-173.
[28] 中华医学会老年医学分会.老年患者6分钟步行试验临床应用中国专家共识[J].中华老年医学杂志,2020,39(11):1241-1250.
[29] RAZA A, STEINBERG K, TARTAGLIA J, et al.Enhanced External Counterpulsation Therapy Past, Present, and Future[J]. CARDIOLOGY IN REVIEW,2017,25(2):59-67.
[30] YANG D-Y, WU G-f.Vasculoprotective properties of enhanced external counterpulsation for coronary artery disease: Beyond the hemodynamics[J].INTERNATIONAL JOURNAL OF CARDIOLOGY,2013,166(1):38-43.